Plasma Apolipoproteins A-I And B In Survivors Of Myocardial Infarction And In a Control Group (Lipids and Lipoproteins)
Clinical Chemistry 1998, Jan, 44, 1
-
- 79,00 Kč
-
- 79,00 Kč
Publisher Description
Several epidemiological studies have confirmed that coronary heart disease (CHD) is associated with lipid abnormalities [1, 2], and intervention studies have demonstrated that a reduction of total and LDL-cholesterol (LDL-C) and an increase of HDL-cholesterol (HDL-C) decrease the risk of CHD [3, 4]. (5) As a result of these studies, the National Cholesterol Education Program (NCEP) published guidelines and defined decisional concentrations for total cholesterol, LDL-C, and HDL-C [5]. It has been postulated for many years that apolipoproteins could be better predictors than lipids for CHD, and many case-control studies have shown that apolipoproteins A-I and B (apo A-I and B) are good
More Books by Clinical Chemistry
Bioinformatics Methods for Prioritizing Serum Biomarker Candidates (Abstract of Oak Ridge Posters)
2006
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005